Priser
Platform
Blog
Om os
Download
DIA
Diagnostyka
Warsaw Stock Exchange
0

Om

Diagnostyka S.A. is a prominent company specializing in medical diagnostics services. It plays an essential role in the healthcare industry by offering a wide range of laboratory tests and medical examinations. With its extensive network of laboratories and collection points, Diagnostyka S.A. ensures accessibility and convenience for patients across various regions. The company's primary function is to deliver accurate and timely diagnostic solutions that aid in disease detection and management, supporting clinicians in providing effective patient care. Its services impact numerous sectors, including hospitals, clinics, and individual healthcare providers, by enhancing their diagnostic capabilities. As a significant player in the market, Diagnostyka S.A. contributes to improving public health outcomes by facilitating informed medical decisions and promoting preventive healthcare practices. With a commitment to quality and innovation, the company continues to expand its offerings and leverage technological advancements to meet the evolving demands of the healthcare sector.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I DIAGNOSTYKA MED ENDAVU: Køb Diagnostyka ($DIA) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Diagnostyka, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerDIA
Land
Australien
Antal medarbejdere7.836
Hjemmesidesilklaser.com.au
SektorSundhed
IndustriMedicinske plejefaciliteter

Udbytter

3,31PLN
'25
Ex-udbytte-dato3. jun. 2025
Udbytteafkast0%